Differential effects of cholesterol and 7-dehydrocholesterol on ligand binding of solubilized hippocampal serotonin<SUB>1A</SUB> receptors: implications in SLOS by Chattopadhyay, Amitabha et al.
www.elsevier.com/locate/ybbrc
Biochemical and Biophysical Research Communications 363 (2007) 800–805Differential effects of cholesterol and 7-dehydrocholesterol
on ligand binding of solubilized hippocampal serotonin1A
receptors: Implications in SLOS
Amitabha Chattopadhyay a,*, Yamuna Devi Paila a, Md. Jafurulla a, Arunima Chaudhuri a,
Pushpendra Singh a, M.R.V.S. Murty b, M. Vairamani b
a Centre for Cellular and Molecular Biology, Hyderabad 500 007, India
b Indian Institute of Chemical Technology, Hyderabad 500 007, India
Received 7 September 2007
Available online 21 September 2007Abstract
The serotonin1A receptor is an important member of the G-protein coupled receptor family, and is involved in the generation and
modulation of a variety of cognitive, behavioral, and developmental functions. Solubilization of the hippocampal serotonin1A receptor
by 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS) is accompanied by loss of membrane cholesterol which
results in a reduction in specific agonist binding activity. Replenishment of cholesterol to solubilized membranes restores the cholesterol
content of the membrane and significantly enhances specific agonist binding activity. In order to test the stringency of the requirement of
cholesterol in this process, we solubilized native hippocampal membranes followed by replenishment with 7-dehydrocholesterol (7-
DHC). 7-DHC is an immediate biosynthetic precursor of cholesterol differing only in a double bond at the 7th position in its sterol ring.
Our results show, for the first time, that replenishment of solubilized hippocampal membranes with 7-DHC does not restore ligand bind-
ing activity of the serotonin1A receptor, in spite of recovery of the overall membrane order. This observation shows that the requirement
for restoration of ligand binding activity is more stringent than the requirement for the recovery of overall membrane order. These novel
results have potential implications in understanding the interaction of membrane sterols with this important neuronal receptor under
pathogenic conditions such as the Smith–Lemli–Opitz syndrome.
 2007 Elsevier Inc. All rights reserved.
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body mass contains 25% of free cholesterol present in
the whole body [2]. Brain cholesterol is synthesized in situ
and is developmentally regulated. As a result, a number
of neurological diseases share a common etiology of defec-
tive cholesterol metabolism in the brain [3]. For example, in
the Smith–Lemli–Opitz syndrome (SLOS), the marked
abnormalities in brain development and function leading
to serious neurological and mental dysfunctions have their
origin in the fact that the major input of brain cholesterol
comes from in situ synthesis and such synthesis is defective
in this syndrome [4]. SLOS is caused by mutations in
3b-hydroxy-steroid-D7-reductase (7-DHCR), an enzyme
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vated plasma levels of 7-dehydrocholesterol (7-DHC) and
the ratio of 7-DHC to cholesterol contents are representa-
tive parameters for the diagnosis of SLOS. Alteration in
the cholesterol content and/or presence of abnormal pre-
cursor sterols in neuronal membranes on receptor function
therefore represents an important determinant in the anal-
ysis of neurogenesis and several neuropathologies.
Previous work from our laboratory has shown the
requirement of membrane cholesterol in the function of
an important neurotransmitter receptor, the serotonin1A
receptor (recently reviewed in [5]). Serotonin receptors rep-
resent one of the largest, evolutionarily ancient, conserved
family of seven transmembrane G-protein coupled recep-
tors (GPCRs) [6,7]. The G-protein coupled serotonin1A
(5-HT1A) receptor is the best characterized among the 14
subtypes of serotonin receptors [8]. Serotonin1A receptors
appear to play a key role in the generation and modulation
of various cognitive, behavioral, and developmental func-
tions such as sleep, mood, addiction, depression, anxiety,
alcohol abuse, aggression, and learning [9]. This is sup-
ported by the fact that agonists and antagonists of the sero-
tonin1A receptor represent major classes of molecules with
potential therapeutic effects in anxiety- or stress-related dis-
orders. Interestingly, mutant (knockout) mice lacking the
serotonin1A receptor exhibit enhanced anxiety-related
behavior, and represent an important animal model for
the analysis of complex traits such as anxiety disorders
and aggression in higher animals [10,11]. Keeping in mind
the pharmacological relevance of the serotonin1A receptor,
which is a transmembrane protein, its interaction with the
surrounding lipid environment assumes greater significance
in modulating its function in healthy and diseased states.
Such lipid–protein interactions can be suitably monitored
if the membrane protein in question is purified. An essen-
tial criterion for purification of an integral membrane pro-
tein is that the protein must be carefully removed from its
native membrane and dispersed in solution. This process,
usually achieved using amphiphilic detergents, is termed
as solubilization [12,13]. We have earlier partially purified
and solubilized the hippocampal serotonin1A receptor in
a functionally active form [14] using CHAPS, a mild,
non-denaturing, and zwitterionic detergent.
A common problem associated with most solubilization
experiments is delipidation, i.e., loss of lipids. This often
leads to considerable loss of activity of the solubilized pro-
tein or receptor since lipid–protein interactions play a cru-
cial role in maintaining the structure and function of
integral membrane proteins and receptors [15]. It has been
previously reported that solubilization of the serotonin1A
receptor by CHAPS leads to reduction in membrane cho-
lesterol and ligand binding activity [16,17]. Interestingly,
we have recently reported that the ligand binding activity
of the serotonin1A receptor could be restored upon replen-
ishment of solubilized membranes with cholesterol [17]. In
order to further examine the stringency of the requirement
of membrane cholesterol in serotonin1A receptor function,we have tested whether 7-DHC, an immediate biosynthetic
precursor of cholesterol differing only in its unsaturation at
7th position in the sterol ring (see Fig. 1), can support the
ligand binding activity of the solubilized hippocampal sero-
tonin1A receptor.Materials and methods
Materials. 7-DHC, cholesterol, CHAPS, coprostanol, DMPC, DPH,
MbCD, EDTA, EGTA, MgCl2, MnCl2, NaCl, Na2HPO4, iodoacetamide,
PEG, PMSF, polyethylenimine, serotonin, sodium azide, sucrose, and Tris
were obtained from Sigma Chemical Co. (St. Louis, MO, USA). BCA
reagent for protein estimation was from Pierce (Rockford, IL, USA).
[3H]8-OH-DPAT (sp. activity 135 Ci/mmol) was purchased from DuPont
New England Nuclear (Boston, MA, USA). GF/B glass microfiber filters
were from Whatman International (Kent, UK). N,O-Bis(trimethyl-
silyl)trifluoroacetamide (BSTFA) was obtained from Supelco (Bellefonte,
PA, USA). Solvents used were of analytical grade. All other chemicals
used were of the highest purity available. Water was purified through a
Millipore (Bedford, MA, USA) Milli-Q system and used throughout.
Fresh bovine brains were obtained from a local slaughterhouse within
10 min of death and the hippocampal region was carefully dissected out.
The hippocampi were immediately flash frozen in liquid nitrogen and
stored at 70 C till further use.
Preparation of native hippocampal membranes. Native hippocampal
membranes were prepared as described earlier [18]. Protein concentration
was determined using the BCA reagent with bovine serum albumin as a
standard [19].
Solubilization of native membranes. Native hippocampal membranes
were solubilized as described earlier using CHAPS [17]. CHAPS-solubi-
lized membrane was precipitated using PEG in order to remove NaCl
from the solubilized extract, since the agonist binding of the serotonin1A
receptor is inhibited by NaCl [20]. This procedure is also believed to
remove the detergent. The PEG-precipitated CHAPS-solubilized mem-
brane was suspended in 50 mM Tris, pH 7.4 buffer and used immediately
either for radioligand binding assays or for sterol replenishment.
7-DHC and cholesterol replenishment of PEG-precipitated solubilized
membranes. PEG-precipitated solubilized membranes were replenished
with 7-dehydrocholesterol (7-DHC) or cholesterol using water soluble
7-DHC–MbCDor cholesterol–MbCDcomplex. The complexwas prepared
by dissolving required amounts of 7-DHC or cholesterol and MbCD in a
ratio of 1:10 (mol/mol) in 50 mMTris, pH 7.4 buffer by constant shaking at
25 C. Stock solutions (typically 2 mM 7-DHC (or cholesterol):20 mM
MbCD) of this complex were freshly prepared before each experiment.
7-DHC and cholesterol replenishment were carried out at a protein con-
centration of 2 mg/ml by incubating the PEG-precipitated solubilized
membranes with 1 mM7-DHC (or cholesterol):10 mMMbCD complex for
30 min in 50 mM Tris, pH 7.4 buffer at 25 C under constant shaking.
Membranes were then spun down at 100,000g for 1 h at 4 C, suspended in
the same buffer, and immediately used for radioligand binding assays.
Gas chromatography and mass spectrometry. GC–MS analysis was
carried out on an Agilent 6890N gas chromatograph (Agilent Technolo-
gies, Palo Alto, CA, USA) equipped with a model 5973i mass selective
detector and 7683 series injector. For membrane sterol measurements,
total lipids were extracted in chloroform–methanol [21], after the addition
of coprostanol as an internal recovery standard. The chloroform phase
obtained was dried under nitrogen. Sterols were identified and quantitated
using GC–MS as described previously [22] with some modifications.
Briefly, an aliquot of the extract was hydrolyzed in 1 M NaOH in ethanol
for 1 h at 70 C, extracted with n-hexane, and converted into trimethylsilyl
ether derivatives followed by injection into a capillary column. This was a
chemically bonded, fused silica, non-polar CP-Sil 8CB (Varian, Middle-
burg, The Netherlands) capillary column (30 m length, 0.25 mm inner
diameter, and 0.25 lm film thickness). To achieve optimal separation of
sterols, the column oven temperature was maintained at 250 C with a
solvent delay of 5 min from the time of injection. Helium at the rate of
Fig. 1. Chemical structures of cholesterol and 7-dehydrocholesterol. The principal route of cholesterol synthesis in humans is the Kandutsch–Russell
pathway [28]. In this pathway, the immediate precursor of cholesterol is 7-DHC which differs only in its unsaturation at 7th position in the sterol ring
(highlighted in its chemical structure). Elevated levels of 7-DHC have been characterized as a diagnostic parameter of the Smith–Lemli–Opitz syndrome.
See text for more details.
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and interface temperatures were kept at 250 and 280 C, respectively. The
ion source and quadrupole temperatures were kept at 230 and 150 C,
respectively. Mass spectra were scanned from 30 to 600 Da under scan
mode. The ions at m/z 329, 351, and 370 were used under selected ion
monitoring (SIM) mode for the estimation of cholesterol, 7-DHC, and
coprostanol, respectively. Sterols were identified using authentic stan-
dards. Peak areas were obtained individually for each compound under
SIM mode in the concentration range of 100–1200 ppm for both choles-
terol and 7-DHC, 100–500 ppm for coprostanol, and the calibration
curves were constructed. The absolute concentrations of various sterols in
the samples were calculated from the calibration curves. The concentra-
tion of coprostanol is used to calculate the recovery of the sterols.
Membrane sterol contents are expressed as lg of sterol/mg of protein.
Estimation of inorganic phosphate. Concentration of lipid phosphate
was determined subsequent to total digestion by perchloric acid [23] using
Na2HPO4 as standard. DMPC was used as an internal standard to assess
lipid digestion. Samples without perchloric acid digestion produced neg-
ligible readings.
Radioligand binding assays. Receptor binding assays were carried out
as described earlier [18]. Briefly, tubes in duplicate with 0.5 mg protein in
a total volume of 1 ml of buffer (50 mM Tris, 1 mM EDTA, 10 mM
MgCl2, 5 mM MnCl2, pH 7.4) were incubated with the radiolabeled
agonist [3H]8-OH-DPAT (final concentration in assay tube being
0.29 nM) for 1 h at 25 C. Non-specific binding was determined by per-
forming the assay in the presence of 10 lM serotonin. The binding reac-
tion was terminated by rapid filtration under vacuum in a Millipore
multiport filtration apparatus through Whatman GF/B 2.5 cm diameter
glass microfiber filters (1.0 lm pore size), which were presoaked in 0.15%
polyethylenimine for 1 h. Filters were then washed three times with 3 ml of
cold water (4 C), dried and the retained radioactivity was measured in a
Packard Tri-Carb 1500 liquid scintillation counter using 5 ml of scintil-
lation fluid.
Fluorescence anisotropy measurements. Fluorescence anisotropy mea-
surements were carried out with fluorescent membrane probe DPH with a
Hitachi F-4010 spectrofluorometer using 1 cm path length quartz cuvettes
at room temperature (23 C) as described earlier [24]. Excitation and
emission wavelengths were set at 358 and 430 nm. Excitation and emission
slits with nominal bandpasses of 1.5 and 20 nm were used. The optical
density of the samples measured at 358 nm was 0.15 ± 0.01. The anisot-
ropy values remained identical even after dilution of membrane samples,
indicating the absence of any scattering artifact [25]. Fluorescence
anisotropy measurements were performed using a Hitachi polarization
accessory. Anisotropy values were calculated from the equation [26]:
r ¼ IVV  GIVH
IVV þ 2GIVHwhere IVV and IVH are the measured fluorescence intensities (after appro-
priate background subtraction) with the excitation polarizer vertically ori-
ented and the emission polarizer vertically and horizontally oriented,respectively. G is the grating correction factor and is equal to IHV/IHH.
All experiments were done with multiple sets of samples and average val-
ues of fluorescence anisotropy are shown in Fig. 4.Results and discussion
Fig. 2 shows the change in sterol contents due to solubi-
lization of native hippocampal membranes and subsequent
replenishment of solubilized membranes with either 7-DHC
or cholesterol. Sterols were separated, identified and quan-
titated using GC–MS. Fig. 2A shows a representative
selected ion chromatogram of 7-DHC, cholesterol, and
coprostanol (used as an internal recovery standard). These
sterols were identified and quantitated using authentic stan-
dards. Fig. 2B shows that there is 50% reduction in the
cholesterol content of hippocampal membranes upon solu-
bilization. This is accompanied by a corresponding reduc-
tion (34%) in the specific [3H]8-OH-DPAT binding (see
Fig. 3). Subsequent treatment of solubilized membranes
with cholesterol–MbCD complex resulted in almost com-
plete replenishment of cholesterol to the original cholesterol
content (see Fig. 2B). This resulted in recovery of specific
agonist binding to 94% of native membranes (Fig. 3). In
order to monitor whether replenishment with 7-DHC could
restore specific [3H]8-OH-DPAT binding, solubilized mem-
branes were replenished with 7-DHC–MbCD complex.
Interestingly, although the conditions of replenishment (ste-
rol–MbCD complex, 1:10 (mol/mol)) were comparable with
conditions used for cholesterol replenishment, specific ago-
nist binding could not be restored (Fig. 3), in spite of the
fact that the extent of loading of 7-DHC was even higher
to what was obtained with cholesterol replenishment
(Fig. 2B). This clearly shows the inability of 7-DHC in sup-
porting specific agonist binding activity of the solubilized
hippocampal serotonin1A receptor.
The observed difference between 7-DHC and choles-
terol, in terms of being able to restore the ligand binding
activity of the solubilized serotonin1A receptor (Fig. 3),
could be due to an alteration in overall membrane organi-
zation (order). In order to monitor whether there is a
change in overall membrane order, fluorescence anisotropy
measurements were carried out with the membrane probe,
DPH. Fluorescence anisotropy measured using probes
Fig. 2. Quantitation of sterols in native hippocampal membranes (control), PEG-precipitated CHAPS-solubilized hippocampal membranes (SM), and
solubilized membranes replenished with either 7-DHC or cholesterol. PEG-precipitated solubilized membranes were replenished with 7-DHC or
cholesterol, using 1 mM 7-DHC (or cholesterol):10 mMMbCD complex. Sterols were separated and quantitated using GC–MS. 7-DHC, cholesterol, and
coprostanol were identified using authentic standards. (A) selected ion chromatogram for coprostanol, cholesterol and 7-DHC obtained from 7-DHC
loaded solubilized membranes. (B) The contents of membrane cholesterol (gray bars), 7-DHC (black bar) from native (control), solubilized membranes
(SM), and solubilized membranes replenished with either 7-DHC or cholesterol. The sterol contents are normalized to protein and are represented as lg/
mg of protein. Data represent means ± SE of at least three independent experiments. See Materials and methods for other details.
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membrane embedded probes [26], which is sensitive to
the packing of lipid chains. Fig. 4 shows that the fluores-
cence anisotropy of DPH exhibits a significant reduction
upon solubilization, possibly due to loss of cholesterol
from native membranes. Interestingly, when solubilized
membranes were replenished with either 7-DHC or choles-
terol, the fluorescence anisotropy was found to increase
and was similar to that of native (control) membranes
(within 10%). This indicates that the overall membrane
order is recovered upon sterol replenishment. This observa-
tion brings out the important point that the requirement
for restoration of ligand binding activity is more stringent
than the requirement for the recovery of overall membrane
order.
We have earlier reported that membrane cholesterol is
required in maintaining ligand binding activity of the solu-bilized hippocampal serotonin1A receptor [17]. In order to
examine the stringency of the requirement of membrane
cholesterol in maintaining the function of the solubilized
serotonin1A receptor, we have replaced cholesterol with 7-
DHC in this work. 7-DHC differs with cholesterol only
in a double bond at the 7th position in the sterol ring (high-
lighted in Fig. 1). Our results show that 7-DHC does not
support the ligand binding activity of the solubilized sero-
tonin1A receptor. This is in spite of the fact that replenish-
ment of the solubilized membrane with 7-DHC restores
overall membrane order to that of native membranes. In
this context, it is important to mention here that we have
previously shown that membrane cholesterol oxidation
leads to inhibition of the ligand binding activity of the hip-
pocampal serotonin1A receptor without any change in
membrane order [27]. This previous result along with our
present results, demonstrate that the molecular basis for
Fig. 3. Effect of replenishment of 7-DHC or cholesterol into PEG-
precipitated CHAPS-solubilized membranes on specific binding of the
[3H]8-OH-DPAT to the hippocampal serotonin1A receptor. Solubilized
membranes were replenished with 7-DHC or cholesterol, using 1 mM 7-
DHC (or cholesterol):10 mM MbCD complex. Values are expressed as
percentages of specific binding obtained in native membranes. Data shown
are means ± SE from at least five independent experiments. See Materials
and methods for other details.
Fig. 4. Effect of replenishment of 7-DHC or cholesterol into PEG-
precipitated CHAPS-solubilized membranes on fluorescence anisotropy of
the membrane probe DPH. Solubilized membranes were replenished with
7-DHC or cholesterol, using 1 mM 7-DHC (or cholesterol):10 mMMbCD
complex. Fluorescence anisotropy experiments were performed with
membranes containing 50 nmol phospholipid at a probe to phospholipid
ratio of 1:100 (mol/mol) at room temperature (23 C). The values
represent means ± SE of duplicate points from at least four independent
experiments. See Materials and methods for other details.
804 A. Chattopadhyay et al. / Biochemical and Biophysical Research Communications 363 (2007) 800–805the requirement of membrane cholesterol in maintaining
the ligand binding activity of serotonin1A receptors could
be specific interaction, although global bilayer effects may
not be ruled out. In addition, our results have potentialimplications in understanding the interaction of membrane
lipids with this important neuronal receptor under SLOS-
like condition.
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